HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

akuammicine

from Strychnos sp;; structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - akuammicine: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - akuammicine: 2

Experts

1.	Boiroju, Naveen Kumar: 1 article (01/2022)
2.	Chincholikar, Mukesh: 1 article (01/2022)
3.	Devaraj, Parasannanavar: 1 article (01/2022)
4.	Dhiman, K S: 1 article (01/2022)
5.	Gaidhani, Sudesh: 1 article (01/2022)
6.	Goel, Sumeet: 1 article (01/2022)
7.	Gundeti, Manohar: 1 article (01/2022)
8.	Hemalatha, Rajkumar: 1 article (01/2022)
9.	Mangal, Anupam: 1 article (01/2022)
10.	Munikumar, Manne: 1 article (01/2022)

Related Diseases

1.	COVID-19 01/01/2022 - "The results provide lead that, the presence of Mpro- Akuammicine N-Oxide with highest Mpro binding energy along with other 34 chemical compounds having similar activity as part of AYUSH-64 make it a suitable candidate for repurposing to management of COVID-19 by further validating through experimental, clinical studies."
2.	Neoplasms (Cancer) 01/01/2017 - "Importantly, akuammicine arises from deformylation of preakuammicine, which is the central biosynthetic precursor for the anti-cancer agents vinblastine and vincristine, as well as other biologically active compounds. "

Related Drugs and Biologics

1.	Oxides
2.	Ayush 64
3.	Vincristine (Oncovin)
4.	Vinblastine (Vinblastine Sulfate)
5.	preakuammicine